2 completed, 2 terminated, 1 recruiting, 1 unknown. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 2, Terminated 2, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Papilledema: new trials by email Literature Review of Papilledema trials Research Report on Papilledema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| B-Complex: A Nutraceutical SANS Countermeasure Vitamin B-Complex Supplement - Optic Disc Edema, Endothelial Dysfunction | Phase 1 | Recruiting | National Aeronautics and Space Administration (NASA) | 16 | 2022-08-01 | 2026-11-12 |
| Endovascular Stenting Treatment for Patients With Internal Jugular Vein Stenosis Venous stenting for internal jugular vein stenosis, One-month routine medical treatment followed by venous stenting for internal jugular vein stenosis - Stent Stenosis, Intracranial Hypertension | Phase 1 | Unknown | Capital Medical University | 60 | 2018-01-01 | 2017-12-14 |
| Stem Cell Transplantation in Ocular Lesions of Behcet's Disease Autologous Stem Cell Transplantation - Retinitis, Behcet's Syndrome | Phase 1 | Terminated | Tehran University of Medical Sciences | 5 | 2007-12-01 | 2015-11-10 |
| Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation Ranibizumab - Telangiectasia | Phase 1 | Completed | National Eye Institute (NEI) | 5 | 2007-03-27 | 2017-07-02 |
| Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation Ranibizumab - Telangiectasia | Phase 1 | Completed | National Eye Institute (NEI) | 5 | 2007-03-27 | 2017-07-02 |
| Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease anakinra - Nervous System Malformations, Arthropathy, Neurogenic | Phase 1 / Phase 2 | Terminated | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 43 | 2003-09-01 | 2016-12-01 |
Idiopathic Juxtafoveal Retinal Telangiectasia (2) · Telangiectasis (2) · Arthropathy, Neurogenic (1) · Behcet Syndrome (1) · Congenital Abnormalities (1) · Cryopyrin-Associated Periodic Syndromes (1) · Headache (1) · Intracranial Hypertension (1) · Joint Diseases (1) · Nervous System Malformations (1) · Retinal Vasculitis (1) · Retinitis (1) · Tinnitus (1) · Urticaria (1)
Cranial Nerve Diseases (6) · Eye Diseases (6) · Nervous System Diseases (6) · Optic Nerve Diseases (6) · Cardiovascular Diseases (3) · Vascular Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hereditary Autoinflammatory Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Brain Diseases (1)
Ranibizumab (2) · Interleukin 1 Receptor Antagonist Protein (1)
National Eye Institute (NEI) (2) · Capital Medical University (1) · National Aeronautics and Space Administration (NASA) (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Tehran University of Medical Sciences (1)
United States (4) · Iran (1)
Behrouz Nikbin, MD (1) · Fereydoun Davatchi, MD (1) · Hormoz Shams, MD (1) · Ran Meng, MD, PhD (1) · Raphaela T Goldbach-Mansky, M.D. (1) · Sara R Zwart, PhD (1) · Xuming Ji, MD, PhD (1)
PMID 16899778, PMID 22294344, PMID 23773637, PMID 25223501, PMID 27143789, PMID 28118536, PMID 33281736
ZIAAR041138-08 (1)